Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin degludec vs insulin detemir in pregnant women with type 1 diabetes
2017-000048-17Phase 3Completed
- Sponsor
- Novo Nordisk
- Start
- Jul 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial of insulin degludec in diabetes mellitus type 1 (T1D) (2 arms), sponsored by Novo Nordisk. Primary endpoint: Last planned HbA1c prior to delivery. Started Jul 2017; status: completed.
02
Drugs
insulin degludec
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2017-000048-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-000048-17.